Dillard LK, Lopez-Perez L, Martinez RX, Fullerton AM, Chadha S, McMahon CM. Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: a systematic review and meta-analysis. Cancer Epidemiol. Aug2022;79: 102203. https://doi.org/10.1016/j.canep.2022.102203.
Article PubMed PubMed Central Google Scholar
Breglio AM, Rusheen AE, Shide ED, Fernandez KA, Spielbauer KK, McLachlin KM, Hall MD, Amable L, Cunningham LL. Cisplatin is retained in the cochlea indefinitely following chemotherapy. Nature Commun. 2017;8(1):1654. https://doi.org/10.1038/s41467-017-01837-1.
Chattaraj A, Syed MP, Low CA, Owonikoko TK. Cisplatin-induced ototoxicity: a concise review of the burden, prevention, and interception strategies. JCO Oncol Pract. 2023;19(5):278–83. https://doi.org/10.1200/op.22.00710.
Article PubMed PubMed Central Google Scholar
Brock PR, Maibach R, Childs M, et al. Sodium thiosulfate for protection from cisplatin-induced hearing loss. N Engl J Med. 2018;378(25):2376–85. https://doi.org/10.1056/NEJMoa1801109.
Article CAS PubMed PubMed Central Google Scholar
Bhandare N, Antonelli PJ, Morris CG, Malayapa RS, Mendenhall WM. Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys. 2007;67(2):469–79. https://doi.org/10.1016/j.ijrobp.2006.09.017.
Bhandare N, Jackson A, Eisbruch A, et al. Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S50–7. https://doi.org/10.1016/j.ijrobp.2009.04.096.
Article PubMed PubMed Central Google Scholar
Schmitt NC, Page BR. Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients. Int J Audiol. 2018;57(sup4):S49-s54. https://doi.org/10.1080/14992027.2017.1353710.
King KA, Brewer CC. Clinical trials, ototoxicity grading scales and the audiologist’s role in therapeutic decision making. Int J Audiol. 2018;57(sup4):S89-s98. https://doi.org/10.1080/14992027.2017.1417644.
Goyal N, Day A, Epstein J, et al. Head and neck cancer survivorship consensus statement from the American Head and Neck Society. Laryngoscope Investig Otolaryngol. 2022;7(1):70–92. https://doi.org/10.1002/lio2.702.
Lee DS, Travis EY, Wong SK, et al. Audiologic follow-up in patients with head and neck cancer treated with cisplatin and radiation. Laryngoscope. 2023;133(11):3161–8. https://doi.org/10.1002/lary.30682.
Article CAS PubMed PubMed Central Google Scholar
Santucci NM, Garber B, Ivory R, Kuhn MA, Stephen M, Aizenberg D. Insight into the current practice of ototoxicity monitoring during cisplatin therapy. J Otolaryngol-Head Neck Surg. 2021;50(1):19. https://doi.org/10.1186/s40463-021-00506-0.
Article CAS PubMed PubMed Central Google Scholar
Lee DS, Travis EY, Wong SK, Munyemana MA, Mueller L, Rowling CC, Rich JT, Pipkorn P, Puram SV, Jackson RS, Adkins DR. Trends in ototoxicity monitoring among cisplatin-treated patients with cancer. J Cancer Survivor. 2024;17:1–1. https://doi.org/10.1007/s11764-024-01586-3.
Meyer C, Hickson L, Lovelock K, Lampert M, Khan A. An investigation of factors that influence help-seeking for hearing impairment in older adults. Int J Audiol. 2014;53(Suppl 1):S3-17. https://doi.org/10.3109/14992027.2013.839888.
Konrad-Martin D, Poling GL, Garinis AC, et al. Applying U.S. national guidelines for ototoxicity monitoring in adult patients: perspectives on patient populations, service gaps, barriers and solutions. Int J Audiol. 2018;57(sup4):S3–18. https://doi.org/10.1080/14992027.2017.1398421.
Holsti OR, ed. The handbook of social psychology. Addison-Wesley; 1968. Lindzey G, Aronson E, eds. Content Analysis.
Nelson J. Using conceptual depth criteria: addressing the challenge of reaching saturation in qualitative research. Qual Res Psychol. 2017;17(5):554–70. https://doi.org/10.1177/1468794116679873.
Saunders B, Sim J, Kingstone T, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52(4):1893–907. https://doi.org/10.1007/s11135-017-0574-8.
Konrad-Martin D, Polaski R, DeBacker JR, et al. Audiologists’ perceived value of ototoxicity management and barriers to implementation for at-risk cancer patients in VA: the OtoMIC survey. J Cancer Surviv. 2023;17(1):69–81. https://doi.org/10.1007/s11764-022-01316-7.
Article PubMed PubMed Central Google Scholar
Pearson SE, Caimino C, Shabbir M, Baguley DM. The impact of chemotherapy-induced inner ear damage on quality of life in cancer survivors: a qualitative study. J Cancer Surviv. 2022;16(5):976–87. https://doi.org/10.1007/s11764-021-01089-5.
Aggarwal P, Nader ME, Gidley PW, et al. Association of hearing loss and tinnitus symptoms with health-related quality of life among long-term oropharyngeal cancer survivors. Cancer Med. 2023;12(1):569–83. https://doi.org/10.1002/cam4.4931.
Article CAS PubMed Google Scholar
Miaskowski C, Mastick J, Paul SM, et al. Impact of chemotherapy-induced neurotoxicities on adult cancer survivors’ symptom burden and quality of life. J Cancer Surviv. 2018;12(2):234–45. https://doi.org/10.1007/s11764-017-0662-8.
Bass JK, Wang F, Thaxton ME, et al. Association of hearing loss with patient-reported functional outcomes in adult survivors of childhood cancer. JNCI J Natl Cancer Inst. 2023. https://doi.org/10.1093/jnci/djad250.
Howren MB, Christensen AJ, Hynds Karnell L, Van Liew JR, Funk GF. Influence of pretreatment social support on health-related quality of life in head and neck cancer survivors: results from a prospective study. Head Neck. 2013;35(6):779–87. https://doi.org/10.1002/hed.23029.
Karnell LH, Christensen AJ, Rosenthal EL, Magnuson JS, Funk GF. Influence of social support on health-related quality of life outcomes in head and neck cancer. Head Neck. 2007;29(2):143–6. https://doi.org/10.1002/hed.20501.
Brook I. Late side effects of radiation treatment for head and neck cancer. Radiat Oncol J. 2020;38(2):84–92. https://doi.org/10.3857/roj.2020.00213.
Article PubMed PubMed Central Google Scholar
Sroussi HY, Epstein JB, Bensadoun RJ, et al. Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Med. 2017;6(12):2918–31. https://doi.org/10.1002/cam4.1221.
Article PubMed PubMed Central Google Scholar
Terrell JE, Nanavati KA, Esclamado RM, Bishop JK, Bradford CR, Wolf GT. Head and neck cancer-specific quality of life: instrument validation. Arch Otolaryngol Head Neck Surg. 1997;123(10):1125–32. https://doi.org/10.1001/archotol.1997.01900100101014.
Article CAS PubMed Google Scholar
Rogers SN LD. The University of Washington Quality of Life Scale. . 2010;Preedy VR, Watson RR, eds. Handbook of Disease Burdens and Quality of Life Measures. . https://doi.org/10.1007/978-0-387-78665-0
Singer S, Amdal CD, Hammerlid E, et al. International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: phase IV. Head Neck. 2019;41(6):1725–37. https://doi.org/10.1002/hed.25609.
D’Antonio LL, Zimmerman GJ, Cella DF, Long SA. Quality of life and functional status measures in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 1996;122(5):482–7. https://doi.org/10.1001/archotol.1996.01890170018005.
Article CAS PubMed Google Scholar
Rosenthal DI, Mendoza TR, Chambers MS, et al. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck. 2007;29(10):923–31. https://doi.org/10.1002/hed.20602.
Comments (0)